Objective-Overproduction of intestinally derived apoB-48-containing triglyceride-rich lipoproteins (TRLs) (chylomicrons) has recently been described in type 2 diabetes, as is known for hepatic TRL-apoB-100 (very-low-density lipoprotein) production. Furthermore, insulin acutely inhibits both intestinal and hepatic TRL production, whereas this acute inhibitory effect on very-low-density lipoprotein production is blunted in type 2 diabetes. It is not currently known whether this acute effect on chylomicron production is similarly blunted in humans with type 2 diabetes. Methods and Results-We investigated the effect of acute hyperinsulinemia on TRL metabolism in 18 type 2 diabetic men using stable isotope methodology. Each subject underwent 1 control (saline infusion [SAL]) lipoprotein turnover study followed by a second study, under 1 of the 3 following clamp conditions: (1) hyperinsulinemic-euglycemic, (2) hyperinsulinemic-hyperglycemic, or (3) hyperinsulinemic-euglycemic plus intralipid and heparin. TRL-apoB-48 and TRL-apoB-100 production and clearance rates were not different between SAL and clamp and between the different clamp conditions, except for significantly lower TRL-apoB-100 clearance and production rates in hyperinsulinemiceuglycemic plus intralipid and heparin clamp compared with SAL. Conclusion-This is the first demonstration in individuals with type 2 diabetes that chylomicron production is resistant to the normal acute suppressive effect of insulin. This phenomenon may contribute to the highly prevalent dyslipidemia of type 2 diabetes and potentially to atherosclerosis. Key Words: apolipoproteins Ⅲ atherosclerosis Ⅲ diabetes mellitus Ⅲ fatty acids Ⅲ lipoproteins T he increased risk of atherosclerotic cardiovascular disease associated with insulin-resistant states and type 2 diabetes is of great public health concern.1 The typical diabetic dyslipidemia is characterized by a number of abnormalities, including elevated plasma triglyceride (TG) levels, low high-density lipoprotein cholesterol, increased proportion of small and dense low-density lipoprotein, and postprandial hyperlipidemia.2 Dyslipidemia in insulin-resistant states contributes to the residual cardiovascular risk and atherosclerosis. [3][4][5] Diabetic dyslipidemia includes characteristic accumulation of triglyceride-rich lipoproteins (TRLs), which has been attributed to a combination of defective TRL removal and overproduction from liver (TRL-apoB-100 or very-low-density lipoprotein [VLDL]) 3 and from intestine (TRLapoB-48 or chylomicrons).6-8 TRL-apoB-48 and TRL-apoB-100 have been identified as proatherogenic in type 2 diabetes.
9The mechanisms leading to the overproduction of TRLs in the setting of type 2 diabetes and insulin resistance remain to be fully characterized, particularly for intestine. We have recently shown that acute elevation of plasma free fatty acids (FFA) stimulates not only hepatic but also intestinal TRL production in Syrian Golden hamsters 10 and in fed healthy humans, 11 demonstrating functional similarities bet...